|
|
||||||||
,
,

,

,
,
,
,
* Department of Laboratory Medicine and Pathology,
Center for Immunology,
Cancer Center, and
Department of Pediatrics, University of Minnesota, Minneapolis, MN 55455
Heat shock protein 70 (hsp70) is a potent adjuvant that links innate and adaptive immune responses. To study how hsp70 activates naive CD8+ T cells in vivo, we tracked Ag-specific CD8+ T cells in mice immunized with a fusion protein containing chicken OVA linked to hsp70 derived from Mycobacterium tuberculosis (OVA.TBhsp70). On a molar basis, OVA.TBhsp70 was several hundred times more effective than OVA peptide plus CFA in eliciting specific CD8+ T cell responses. Immunization with OVA.TBhsp70 activated >90% of detectable OVA-specific CD8+ T cells within 3 days and led to the persistence of cytotoxic effectors for at least 17 days. These studies demonstrate that the potent adjuvant effect of M. tuberculosis hsp70 results from the relatively complete, rapid, and durable activation of Ag-specific CD8+ T cells.
This article has been cited by other articles:
![]() |
B. Valentinis, A. Capobianco, F. Esposito, A. Bianchi, P. Rovere-Querini, A. A. Manfredi, and C. Traversari Human recombinant heat shock protein 70 affects the maturation pathways of dendritic cells in vitro and has an in vivo adjuvant activity J. Leukoc. Biol., July 1, 2008; 84(1): 199 - 206. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Boyman, C. Ramsey, D. M. Kim, J. Sprent, and C. D. Surh IL-7/Anti-IL-7 mAb Complexes Restore T Cell Development and Induce Homeostatic T Cell Expansion without Lymphopenia J. Immunol., June 1, 2008; 180(11): 7265 - 7275. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Liu, B. H. Wu, G. J. Rowse, and P. C. R. Emtage Induction of CD4-Independent E7-Specific CD8+ Memory Response by Heat Shock Fusion Protein Clin. Vaccine Immunol., August 1, 2007; 14(8): 1013 - 1023. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Ye and Y.-H. Gan Flagellin Contamination of Recombinant Heat Shock Protein 70 Is Responsible for Its Activity on T Cells J. Biol. Chem., February 16, 2007; 282(7): 4479 - 4484. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Bulut, K. S. Michelsen, L. Hayrapetian, Y. Naiki, R. Spallek, M. Singh, and M. Arditi Mycobacterium Tuberculosis Heat Shock Proteins Use Diverse Toll-like Receptor Pathways to Activate Pro-inflammatory Signals J. Biol. Chem., June 3, 2005; 280(22): 20961 - 20967. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. R. Tobian, C. V. Harding, and D. H. Canaday Mycobacterium tuberculosis Heat Shock Fusion Protein Enhances Class I MHC Cross-Processing and -Presentation by B Lymphocytes J. Immunol., May 1, 2005; 174(9): 5209 - 5214. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. R. Tobian, D. H. Canaday, W. H. Boom, and C. V. Harding Bacterial Heat Shock Proteins Promote CD91-Dependent Class I MHC Cross-Presentation of Chaperoned Peptide to CD8+ T Cells by Cytosolic Mechanisms in Dendritic Cells versus Vacuolar Mechanisms in Macrophages J. Immunol., May 1, 2004; 172(9): 5277 - 5286. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. K. Rapp and S. H. Kaufmann DNA vaccination with gp96-peptide fusion proteins induces protection against an intracellular bacterial pathogen Int. Immunol., April 1, 2004; 16(4): 597 - 605. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |